Clinical trial
The Microvascular Function of GLP-1 and Its Analogues in Humans, in Vivo: the Role of DPP-IV Inhibition
NCT01677104 is registered in ClinicalTrials.gov with Katarina Kos as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Microvascular Function of GLP-1 and Its Analogues in Humans, in Vivo: the Role of DPP-IV Inhibition
- Lead sponsor
- Katarina Kos
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- July 31, 2014
- Enrollment
- 63 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obesity, type 2 diabetes